Skip to main content
Top
Published in: BMC Nephrology 1/2022

Open Access 01-12-2022 | Chronic Kidney Disease | Research

Associations of sodium and potassium intake with chronic kidney disease in a prospective cohort study: findings from the Hispanic Community Health Study/Study of Latinos, 2008–2017

Authors: Samuel L. Swift, Yelena Drexler, Daniela Sotres-Alvarez, Leopoldo Raij, Maria M. Llabre, Neil Schneiderman, Linda Van Horn, James P. Lash, Yasmin Mossavar-Rahmani, Tali Elfassy

Published in: BMC Nephrology | Issue 1/2022

Login to get access

Abstract

Background

According to dietary recommendations, reduction of sodium intake has potential to reduce Chronic Kidney Disease (CKD) risk; however the role of dietary potassium and the sodium -to- potassium ratio in the development of CKD is unclear.

Methods

We studied 9778 participants of the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) from four US urban communities. Participants were aged 18–74 yrs., free from CKD at baseline in 2008–2011 and re-examined between 2014 and − 2017. Dietary intake of sodium, potassium and the ratio of dietary sodium -to- potassium were measured from two baseline 24-h dietary recalls. Incident CKD was defined as: 1) estimated glomerular filtration rate (eGFR) decline of 1 unit per year and eGFR < 60 ml/min/1.73m2 or 2) albumin to creatinine ratio ≥ 30 mg/g at the follow-up visit. We used multivariable survey weighted Poisson regression to estimate adjusted incident rates of incident CKD.

Results

At baseline, mean age was 41 years. Average follow up time was 6.2 years. From fully adjusted Poisson regression analyses, self-reported sodium intake was not associated with incident CKD. However, for each 500 mg decrement in potassium intake, there was an 11% increase risk of incident CKD (IRR = 1.11, 95% CI = 1.00, 1.24). Additionally, every 1 M ratio increment of sodium -to -potassium ratio was associated with a 21% increased risk of incident CKD (IRR = 1.21, 95% CI = 1.02, 1.45), p < 0.05).

Conclusions

We conclude that diets low in potassium and high in sodium are associated with increased risk of developing chronic kidney disease among healthy US Hispanic/Latino adults.
Appendix
Available only for authorised users
Literature
3.
go back to reference Ricardo AC, Flessner MF, Eckfeldt JH, et al. Prevalence and correlates of CKD in Hispanics/Latinos in the United States. Clin J Am Soc Nephrol. 2015;10(10):1757–66.CrossRef Ricardo AC, Flessner MF, Eckfeldt JH, et al. Prevalence and correlates of CKD in Hispanics/Latinos in the United States. Clin J Am Soc Nephrol. 2015;10(10):1757–66.CrossRef
9.
go back to reference Verhave JC, Hillege HL, Burgerhof JG, et al. Sodium intake affects urinary albumin excretion especially in overweight subjects. J Intern Med. 2004;256(4):324–30.CrossRef Verhave JC, Hillege HL, Burgerhof JG, et al. Sodium intake affects urinary albumin excretion especially in overweight subjects. J Intern Med. 2004;256(4):324–30.CrossRef
11.
go back to reference Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis. 2000;35(6 Suppl 2):S1–140. Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis. 2000;35(6 Suppl 2):S1–140.
12.
go back to reference James PAOS, Carter BL, Cushman WC, Dennison-Himmelfarb C, et al. 2014 evidence based guideline for the Management of High Blood Pressure in adults report from the panel members appointed to the eighth joint National Committe (JNC8). JAMA. 2014;311(5):507–20.CrossRef James PAOS, Carter BL, Cushman WC, Dennison-Himmelfarb C, et al. 2014 evidence based guideline for the Management of High Blood Pressure in adults report from the panel members appointed to the eighth joint National Committe (JNC8). JAMA. 2014;311(5):507–20.CrossRef
13.
go back to reference Verbeke F, Lindley E, Van Bortel L, et al. A European renal best practice (ERBP) position statement on the kidney disease: improving global outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with some caveats for real-life application. Nephrol Dial Transplant. 2014;29(3):490–6. https://doi.org/10.1093/ndt/gft321.CrossRefPubMed Verbeke F, Lindley E, Van Bortel L, et al. A European renal best practice (ERBP) position statement on the kidney disease: improving global outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with some caveats for real-life application. Nephrol Dial Transplant. 2014;29(3):490–6. https://​doi.​org/​10.​1093/​ndt/​gft321.CrossRefPubMed
17.
go back to reference Nagata T, Sobajima H, Ohashi N, et al. Association between 24h urinary sodium and potassium excretion and estimated glomerular filtration rate (eGFR) decline or death in patients with diabetes mellitus and eGFR more than 30 ml/min/1.73 m2. PLoS One. 2016;11(5):e0152306.CrossRef Nagata T, Sobajima H, Ohashi N, et al. Association between 24h urinary sodium and potassium excretion and estimated glomerular filtration rate (eGFR) decline or death in patients with diabetes mellitus and eGFR more than 30 ml/min/1.73 m2. PLoS One. 2016;11(5):e0152306.CrossRef
19.
go back to reference Deriaz D, Guessous I, Vollenweider P, et al. Estimated 24-h urinary sodium and sodium-to-potassium ratio are predictors of kidney function decline in a population-based study. J Hypertens. 2019;37(9):1853–60.CrossRef Deriaz D, Guessous I, Vollenweider P, et al. Estimated 24-h urinary sodium and sodium-to-potassium ratio are predictors of kidney function decline in a population-based study. J Hypertens. 2019;37(9):1853–60.CrossRef
20.
go back to reference He J, Mills KT, Appel LJ, et al. Urinary sodium and potassium excretion and CKD progression. J Am Soc Nephrol. 2016;27(4):1202–12.CrossRef He J, Mills KT, Appel LJ, et al. Urinary sodium and potassium excretion and CKD progression. J Am Soc Nephrol. 2016;27(4):1202–12.CrossRef
21.
go back to reference Ogata S, Akashi Y, Sakusabe T, et al. A multiple 24 h urine collection study indicates that kidney function decline is related to urinary sodium and potassium excretion in patients with chronic kidney disease. Kidney Int. 2021; Ogata S, Akashi Y, Sakusabe T, et al. A multiple 24 h urine collection study indicates that kidney function decline is related to urinary sodium and potassium excretion in patients with chronic kidney disease. Kidney Int. 2021;
22.
go back to reference Yoon C-Y, Noh J, Lee J, et al. High and low sodium intakes are associated with incident chronic kidney disease in patients with normal renal function and hypertension. Kidney Int. 2018;93(4):921–31.CrossRef Yoon C-Y, Noh J, Lee J, et al. High and low sodium intakes are associated with incident chronic kidney disease in patients with normal renal function and hypertension. Kidney Int. 2018;93(4):921–31.CrossRef
23.
go back to reference Thomas MC, Moran J, Forsblom C, et al. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care. 2011;34(4):861–6.CrossRef Thomas MC, Moran J, Forsblom C, et al. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care. 2011;34(4):861–6.CrossRef
24.
go back to reference Vegter S, Perna A, Postma MJ, Navis G, Remuzzi G, Ruggenenti P. Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol. 2012;23(1):165–73.CrossRef Vegter S, Perna A, Postma MJ, Navis G, Remuzzi G, Ruggenenti P. Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol. 2012;23(1):165–73.CrossRef
25.
go back to reference Fan L, Tighiouart H, Levey AS, Beck GJ, Sarnak MJ. Urinary sodium excretion and kidney failure in nondiabetic chronic kidney disease. Kidney Int. 2014;86(3):582–8.CrossRef Fan L, Tighiouart H, Levey AS, Beck GJ, Sarnak MJ. Urinary sodium excretion and kidney failure in nondiabetic chronic kidney disease. Kidney Int. 2014;86(3):582–8.CrossRef
26.
go back to reference McQuarrie EP, Traynor JP, Taylor AH, et al. Association between urinary sodium, creatinine, albumin, and long-term survival in chronic kidney disease. Hypertension. 2014;64(1):111–7.CrossRef McQuarrie EP, Traynor JP, Taylor AH, et al. Association between urinary sodium, creatinine, albumin, and long-term survival in chronic kidney disease. Hypertension. 2014;64(1):111–7.CrossRef
27.
go back to reference Smyth A, Dunkler D, Gao P, et al. The relationship between estimated sodium and potassium excretion and subsequent renal outcomes. Kidney Int. 2014;86(6):1205–12.CrossRef Smyth A, Dunkler D, Gao P, et al. The relationship between estimated sodium and potassium excretion and subsequent renal outcomes. Kidney Int. 2014;86(6):1205–12.CrossRef
28.
go back to reference Araki S-i, Haneda M, Koya D, et al. Urinary potassium excretion and renal and cardiovascular complications in patients with type 2 diabetes and normal renal function. Clin J Am Soc Nephrol. 2015;10(12):2152–8.CrossRef Araki S-i, Haneda M, Koya D, et al. Urinary potassium excretion and renal and cardiovascular complications in patients with type 2 diabetes and normal renal function. Clin J Am Soc Nephrol. 2015;10(12):2152–8.CrossRef
29.
go back to reference Ricardo AC, Loop MS, Gonzalez F, et al. Incident chronic kidney disease risk among Hispanics/Latinos in the United States: the Hispanic community health study/study of Latinos (HCHS/SOL). J Am Soc Nephrol. 2020;31(6):1315–24.CrossRef Ricardo AC, Loop MS, Gonzalez F, et al. Incident chronic kidney disease risk among Hispanics/Latinos in the United States: the Hispanic community health study/study of Latinos (HCHS/SOL). J Am Soc Nephrol. 2020;31(6):1315–24.CrossRef
31.
go back to reference Rodriguez CJAM, Daviglus ML, Isasi CR, Keller C, et al. Status of cardiovascular disease and stroke in Hispanics/Latinos in the United States: a science advisory from the American Heart Association. Circulation. 2014;130(7):593–625.CrossRef Rodriguez CJAM, Daviglus ML, Isasi CR, Keller C, et al. Status of cardiovascular disease and stroke in Hispanics/Latinos in the United States: a science advisory from the American Heart Association. Circulation. 2014;130(7):593–625.CrossRef
32.
go back to reference LaVange LM, Kalsbeek WD, Sorlie PD, et al. Sample design and cohort selection in the Hispanic community health study/study of Latinos. Ann Epidemiol. 2010;20(8):642–9.CrossRef LaVange LM, Kalsbeek WD, Sorlie PD, et al. Sample design and cohort selection in the Hispanic community health study/study of Latinos. Ann Epidemiol. 2010;20(8):642–9.CrossRef
34.
go back to reference SAS Institute Inc 2013. SAS/ACCESS® 9.4 Interface to ADABAS: Reference. Cary: SAS Institute Inc. SAS Institute Inc 2013. SAS/ACCESS® 9.4 Interface to ADABAS: Reference. Cary: SAS Institute Inc.
35.
go back to reference Henney J, Taylor C, Boon C. Institute of Medicine (US) Committee on Strategies to Reduce Sodium Intake. Washington (DC): National Academies Press (US); 2010. ISBN-13: 978-0-309-14805-4ISBN-13: 978-0-309-14806-1. Henney J, Taylor C, Boon C. Institute of Medicine (US) Committee on Strategies to Reduce Sodium Intake. Washington (DC): National Academies Press (US); 2010. ISBN-13: 978-0-309-14805-4ISBN-13: 978-0-309-14806-1.
36.
go back to reference Mossavar-Rahmani Y, Sotres-Alvarez D, Wong WW, et al. Applying recovery biomarkers to calibrate self-report measures of sodium and potassium in the Hispanic community health study/study of Latinos. J Hum Hypertens. 2017;31(7):462–73.CrossRef Mossavar-Rahmani Y, Sotres-Alvarez D, Wong WW, et al. Applying recovery biomarkers to calibrate self-report measures of sodium and potassium in the Hispanic community health study/study of Latinos. J Hum Hypertens. 2017;31(7):462–73.CrossRef
38.
39.
go back to reference Thyagarajan B, Howard AG, Durazo-Arvizu R, et al. Analytical and biological variability in biomarker measurement in the Hispanic community health study/study of Latinos. Clin Chim Acta. 2016;463:129–37.CrossRef Thyagarajan B, Howard AG, Durazo-Arvizu R, et al. Analytical and biological variability in biomarker measurement in the Hispanic community health study/study of Latinos. Clin Chim Acta. 2016;463:129–37.CrossRef
43.
go back to reference El Assaad MA, Topouchian JA, Darné BM, Asmar RG. Validation of the Omron HEM-907 device for blood pressure measurement. Am J Hypertens. 2002;15(S3):87A.CrossRef El Assaad MA, Topouchian JA, Darné BM, Asmar RG. Validation of the Omron HEM-907 device for blood pressure measurement. Am J Hypertens. 2002;15(S3):87A.CrossRef
45.
go back to reference Sorlie PD, Avilés-Santa LM, Wassertheil-Smoller S, et al. Design and implementation of the Hispanic community health study/study of Latinos. Ann Epidemiol. 2010;20(8):629–41.CrossRef Sorlie PD, Avilés-Santa LM, Wassertheil-Smoller S, et al. Design and implementation of the Hispanic community health study/study of Latinos. Ann Epidemiol. 2010;20(8):629–41.CrossRef
46.
go back to reference Selvin S. Statistical analysis of epidemiologic data. USA: Oxford University Press; 2004. Selvin S. Statistical analysis of epidemiologic data. USA: Oxford University Press; 2004.
47.
go back to reference McGuire S. Scientific report of the 2015 dietary guidelines advisory committee. Washington, DC: US Departments of agriculture and health and human services, 2015. Adv Nutr. 2016;7(1):202–4.CrossRef McGuire S. Scientific report of the 2015 dietary guidelines advisory committee. Washington, DC: US Departments of agriculture and health and human services, 2015. Adv Nutr. 2016;7(1):202–4.CrossRef
48.
go back to reference Food, drug administration H. food labeling: revision of the nutrition and supplement facts labels. Final rule. Fed Regist. 2016;81(103):33741–999. Food, drug administration H. food labeling: revision of the nutrition and supplement facts labels. Final rule. Fed Regist. 2016;81(103):33741–999.
49.
go back to reference Raia JJ Jr, Barone JA, Byerly WG, Lacy CR. Angiotensin-converting enzyme inhibitors: a comparative review. DICP. 1990;24(5):506–25.CrossRef Raia JJ Jr, Barone JA, Byerly WG, Lacy CR. Angiotensin-converting enzyme inhibitors: a comparative review. DICP. 1990;24(5):506–25.CrossRef
50.
51.
go back to reference Boushey CJ, Coulston AM, Rock CL, Monsen E. Nutrition in the prevention and treatment of disease. Elsevier; 2001. Boushey CJ, Coulston AM, Rock CL, Monsen E. Nutrition in the prevention and treatment of disease. Elsevier; 2001.
52.
go back to reference Perez V, Chang ET. Sodium-to-potassium ratio and blood pressure, hypertension, and related factors. Adv Nutr. 2014;5(6):712–41.CrossRef Perez V, Chang ET. Sodium-to-potassium ratio and blood pressure, hypertension, and related factors. Adv Nutr. 2014;5(6):712–41.CrossRef
53.
go back to reference Du S, Neiman A, Batis C, et al. Understanding the patterns and trends of sodium intake, potassium intake, and sodium to potassium ratio and their effect on hypertension in China. Am J Clin Nutr. 2014;99(2):334–43.CrossRef Du S, Neiman A, Batis C, et al. Understanding the patterns and trends of sodium intake, potassium intake, and sodium to potassium ratio and their effect on hypertension in China. Am J Clin Nutr. 2014;99(2):334–43.CrossRef
54.
go back to reference Cook NR, Obarzanek E, Cutler JA, et al. Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the trials of hypertension prevention follow-up study. Arch Intern Med. 2009;169(1):32–40.CrossRef Cook NR, Obarzanek E, Cutler JA, et al. Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the trials of hypertension prevention follow-up study. Arch Intern Med. 2009;169(1):32–40.CrossRef
55.
go back to reference Yang Q, Liu T, Kuklina EV, et al. Sodium and potassium intake and mortality among US adults: prospective data from the third National Health and nutrition examination survey. Arch Intern Med. 2011;171(13):1183–91.CrossRef Yang Q, Liu T, Kuklina EV, et al. Sodium and potassium intake and mortality among US adults: prospective data from the third National Health and nutrition examination survey. Arch Intern Med. 2011;171(13):1183–91.CrossRef
56.
go back to reference Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med. 2001;344(1):3–10.CrossRef Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med. 2001;344(1):3–10.CrossRef
57.
go back to reference Rebholz CM, Crews DC, Grams ME, et al. DASH (dietary approaches to stop hypertension) diet and risk of subsequent kidney disease. Am J Kidney Dis. 2016;68(6):853–61.CrossRef Rebholz CM, Crews DC, Grams ME, et al. DASH (dietary approaches to stop hypertension) diet and risk of subsequent kidney disease. Am J Kidney Dis. 2016;68(6):853–61.CrossRef
58.
go back to reference He FJ, MacGregor GA. Plasma sodium and hypertension. Kidney Int. 2004;66(6):2454–66.CrossRef He FJ, MacGregor GA. Plasma sodium and hypertension. Kidney Int. 2004;66(6):2454–66.CrossRef
60.
go back to reference Castro H, Raij L. Potassium in hypertension and cardiovascular disease. Semin Nephrol. 2013:33(3):277–89. Castro H, Raij L. Potassium in hypertension and cardiovascular disease. Semin Nephrol. 2013:33(3):277–89.
61.
go back to reference Lin H, Young DB, Smith MJ Jr. Stimulation of renin release by hyperkalemia in the nonfiltering kidney. Am J Physiol-Renal Physiol. 1991;260(2):F170–6.CrossRef Lin H, Young DB, Smith MJ Jr. Stimulation of renin release by hyperkalemia in the nonfiltering kidney. Am J Physiol-Renal Physiol. 1991;260(2):F170–6.CrossRef
62.
go back to reference Vääräniemi K, Koskela J, Tahvanainen A, et al. Lower glomerular filtration rate is associated with higher systemic vascular resistance in patients without prevalent kidney disease. J Clin Hypertens. 2014;16(10):722–8.CrossRef Vääräniemi K, Koskela J, Tahvanainen A, et al. Lower glomerular filtration rate is associated with higher systemic vascular resistance in patients without prevalent kidney disease. J Clin Hypertens. 2014;16(10):722–8.CrossRef
63.
go back to reference Jin L, Chao L, Chao J. Potassium supplement upregulates the expression of renal kallikrein and bradykinin B2receptor in SHR. Am J Physiol-Renal Physiol. 1999;276(3):F476–84.CrossRef Jin L, Chao L, Chao J. Potassium supplement upregulates the expression of renal kallikrein and bradykinin B2receptor in SHR. Am J Physiol-Renal Physiol. 1999;276(3):F476–84.CrossRef
65.
go back to reference Mercado CI, Cogswell ME, Valderrama AL, et al. Difference between 24-h diet recall and urine excretion for assessing population sodium and potassium intake in adults aged 18–39 y. Am J Clin Nutr. 2015;101(2):376–86.CrossRef Mercado CI, Cogswell ME, Valderrama AL, et al. Difference between 24-h diet recall and urine excretion for assessing population sodium and potassium intake in adults aged 18–39 y. Am J Clin Nutr. 2015;101(2):376–86.CrossRef
68.
go back to reference Loftfield E, Yi S, Curtis CJ, Bartley K, Kansagra SM. Potassium and fruit and vegetable intakes in relation to social determinants and access to produce in new York City. Am J Clin Nutr. 2013;98(5):1282–8.CrossRef Loftfield E, Yi S, Curtis CJ, Bartley K, Kansagra SM. Potassium and fruit and vegetable intakes in relation to social determinants and access to produce in new York City. Am J Clin Nutr. 2013;98(5):1282–8.CrossRef
Metadata
Title
Associations of sodium and potassium intake with chronic kidney disease in a prospective cohort study: findings from the Hispanic Community Health Study/Study of Latinos, 2008–2017
Authors
Samuel L. Swift
Yelena Drexler
Daniela Sotres-Alvarez
Leopoldo Raij
Maria M. Llabre
Neil Schneiderman
Linda Van Horn
James P. Lash
Yasmin Mossavar-Rahmani
Tali Elfassy
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2022
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-022-02754-2

Other articles of this Issue 1/2022

BMC Nephrology 1/2022 Go to the issue